Translating Science into Clinical Practice New and Evolving Anti-inflammatory MS Therapies
Event start date and time: October 11, 2013 5:00 PM
Event end date and time: October 11, 2013 5:00 PM
Translating Science into Clinical Practice: New and Evolving Anti-Inflammatory MS Therapies
This educational activity has been supported by a grant from Biogen Idec and Sanofi-Aventis US Genzyme .
Target Audience:The intended audience for this activity is neurologists, neurology residents and fellows, MS researchers, physician assistants, and nursing professionals.
Program Overview: The Consortium of Multiple Sclerosis Centers cordially invites you to join our distinguished neurologic panel in an accredited educational activity designed for physicians and nursing professionals who specialize or have an interest in multiple sclerosis (MS). Co-chaired by Dr. Kottil Rammohan and Dr. Michael Kaufman, our internationally known faculty will present cutting-edge information about the benefits and risks of new and emerging therapies in MS.
- Demonstrate increased current understanding of the immunology of multiple sclerosis in order to facilitate evidence-based decisions in the choice of disease modifying agents.
- Analyze adverse events, monitoring procedures, or possible drug interactions associated with current and emerging disease modifying therapies to improve patient assessment and monitoring by MS healthcare professionals.
- Modify patient management strategies by incorporating information drawn from this conference along with a range of evidence including peer-reviewed publications, clinical trials, other live meetings, and expert opinion.
- To Register
Registration will not be accepted via telephone.
Pre-registration is strongly encouraged. We cannot guarantee that we can accommodate on-site registrations.
Questions Please email firstname.lastname@example.org or call (201) 487-10
• Post ID: 15431509 newjersey